Asthma Canada Home
  • Get Help
    • Speak to an Expert
    • Check Your Asthma
    • Resources & Tools
    • Asthma Action Plans
    • Educational Webinars
    • Educational Game for Kids
  • About Asthma
    • Understanding Asthma
    • Diagnosing Asthma
    • Living with Asthma
    • Controlling Asthma
    • Asthma Triggers
    • Severe Asthma
    • Children & Asthma
      • Educational Game for Kids
      • Resources for School
    • Allergies & Asthma
    • Wildfires & Asthma
    • Vaccines & Asthma
    • A.C.T. on Asthma
  • About Us
    • Our Strategy
    • What We Do
      • Education
        • Asthma & Allergy HelpLine
      • Research
      • Advocacy
    • Our History
    • Our Staff
    • Our HelpLine Staff
    • Our Medical & Scientific Experts
    • Our Board of Directors
    • Our Annual Reports
    • Contact Us
  • Research
    • Our Research Strategy
    • Our Research Programme
    • Research Publications
  • News & Updates
  • Get Involved
    • Ways to Give
      • Make a Donation
      • Host a Fundraiser
      • Leave a Gift in Your Will
      • Gift of Securities
    • How Funding Helps
    • Corporate Partnerships
      • Our Partners
    • Share Your Story
      • Community Stories
    • Join ACMA
  • Donate

404

Oops, This page not Found !

Back to Home

Instagram

🌟 Awardee Spotlight: Jenysbel Hernandez Reyes 🌟 We’re excited to introduce Jenysbel, a recipient of our 2025 Graduate Student Research Awards 🎓💙 Jenysbel is pursuing her PhD in Microbiology and Immunology at Dalhousie University under the supervision of Dr. Jean S. Marshall. With experience in clinical-stage immunotherapy research, she is passionate about translating science into real-world treatments. Research Project: 'Development of a novel, targeted, cell-based immunotherapy for the treatment of asthma' Severe allergic asthma is often difficult to treat, and current therapies may only manage symptoms. Jenysbel’s project explores a potential new approach using CAAR-T cells, engineered immune cells designed to specifically target and eliminate IgE-producing B cells that drive allergic asthma. Her research will test whether these modified T cells can selectively remove harmful cells in lab models and in mice with asthma, while preserving the rest of the immune system. She will also compare treatment before and after symptom onset. If effective, this approach may offer a long-lasting and targeted therapy for severe asthma in the future. Join us in applauding Jenysbel and supporting her impactful research! ✨ #asthma #asthmaResearch #Research | @dalhousieu | @dalscience
Asthma Canada would like to extend a heartfelt tha Asthma Canada would like to extend a heartfelt thank you to everyone who took part in the TCS Waterfront events this weekend in support of the 4.7 million people with asthma in Canada. 💙 Whether you joined the run, walked alongside the team, helped fundraise or showed support, you were part of something important. Your support helps us: 🔹 Provide trusted education and resources to help people better understand and manage their asthma 🔹 Support vital research that drives innovation and improves treatment options 🔹 Advocate for better policies, access to care, and awareness so that no one is left behind We also want to thank everyone who has donated so far. Our goal: $10,000 So far, we’ve raised: $9,290, $710 to go! We’re so close—can you help us reach the finish line? Link to donate in story. Thank you for helping us improve the lives of people with asthma in Canada. 💙
🌟 Awardee Spotlight: Oscar Gonzalez-Morales 🌟 We’re excited to introduce Oscar, a recipient of our 2025 Graduate Student Research Awards 🎓💙 Oscar is an MSc student in Immunology at the University of Manitoba, working in Dr. Neeloffer Mookherjee’s lab. With a background in biotechnology and therapeutic development, he is passionate about solutions for severe asthma. Research Project: 'Effect of cationic host defence peptides on HDAC2 and related pathways in steroid-unresponsive asthma' Approximately 10–15% of asthma patients do not respond to steroid treatments. Oscar’s research explores Innate Defence Regulator (IDR) peptides, which his lab has observed to reduce inflammation and improve lung function in experimental models. His project will examine how IDR peptides may help restore levels of HDAC2, a protein that is reduced in steroid-resistant asthma and is linked to treatment failure. By studying this pathway, he aims to uncover how IDR peptides could support future therapeutic strategies. Oscar’s work may help identify new targets for treating severe, steroid-unresponsive asthma. Join us in congratulating Oscar on his innovative research! ✨ @umanitoba | #asthma #asthmaResearch #Research @mb_lung_association
We’re SO close! A huge THANK YOU to everyone t We’re SO close! A huge THANK YOU to everyone taking part in the TCS Waterfront events this week on behalf of Asthma Canada. 💙 And an extra thank you to every single person who has already donated to support our participants—you are making a real difference for the 4.7 million people in Canada living with asthma. 🎯 Goal: $10,000 ✅ Raised so far: $7,252.33 We’re almost there—can you help us cross the finish line? Every dollar brings us closer to life-changing education, research, and advocacy. Donate through link in our story. Let’s do this together! #asthma #asthmaawareness #towaterfront42k @towaterfront42k #TOwaterfront42K #chooseTOrun
Follow on Instagram

Helpful links

9

About Asthma

9

Get Help

9

Get Involved

9

FAQ

9

Resources

9

News & Updates

9

Careers & Volunteer Opportunities

Contact Us



124 Merton St. Unit 401 Toronto, ON M4S 2Z2



1-866-787-4050



info@asthma.ca

Charitable Registration Number:

89853-7048-RR0001

  • Follow
  • Follow
  • Follow
  • Follow

Subscribe 

Sign-up to have the latest asthma news and information delivered to your inbox.

Subscribe

2025 © All Rights Reserved | Media | Privacy | Terms of Use